BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarmento-Ribeiro AB, Scorilas A, Gonçalves AC, Efferth T, Trougakos IP. The emergence of drug resistance to targeted cancer therapies: Clinical evidence. Drug Resist Updat 2019;47:100646. [PMID: 31733611 DOI: 10.1016/j.drup.2019.100646] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Su Z, Dong S, Zhao SC, Liu K, Tan Y, Jiang X, Assaraf YG, Qin B, Chen ZS, Zou C. Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updat 2021;58:100777. [PMID: 34481195 DOI: 10.1016/j.drup.2021.100777] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li Y, Azmi AS, Mohammad RM. Deregulated transcription factors and poor clinical outcomes in cancer patients. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.08.001] [Reference Citation Analysis]
3 Lai W, Li X, Kong Q, Chen H, Li Y, Xu LH, Fang J. Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells. Cancer Cell Int 2021;21:700. [PMID: 34933679 DOI: 10.1186/s12935-021-02387-9] [Reference Citation Analysis]
4 Endo Y, Wu WJ. Tumor Extrinsic Factors Mediate Primary T-DM1 Resistance in HER2-Positive Breast Cancer Cells. Cancers (Basel) 2021;13:2331. [PMID: 34066157 DOI: 10.3390/cancers13102331] [Reference Citation Analysis]
5 Arulkumar M, Yang K, Wang N, Penislusshiyan S, Palvannan T, Ramalingam K, Chen F, Luo S, Zhou Y, Wang Z. Synthesis of benzimidazole/triphenylamine-based compounds, evaluation of their bioactivities and an in silico study with receptor tyrosine kinases. New J Chem 2022;46:675-85. [DOI: 10.1039/d1nj05073g] [Reference Citation Analysis]
6 Khot VM, Salunkhe AB, Pricl S, Bauer J, Thorat ND, Townley H. Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance. Drug Discov Today 2021;26:724-39. [PMID: 33359624 DOI: 10.1016/j.drudis.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Qorri B, Mokhtari RB, Harless WW, Szewczuk MR. Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression. Cancers (Basel) 2022;14:1374. [PMID: 35326525 DOI: 10.3390/cancers14061374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Murphy H, McCarthy G, Dobrovolny HM. Understanding the effect of measurement time on drug characterization. PLoS One 2020;15:e0233031. [PMID: 32407356 DOI: 10.1371/journal.pone.0233031] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zimmermann-Klemd AM, Reinhardt JK, Winker M, Gründemann C. Phytotherapy in Integrative Oncology-An Update of Promising Treatment Options. Molecules 2022;27:3209. [PMID: 35630688 DOI: 10.3390/molecules27103209] [Reference Citation Analysis]
10 Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y, Huang C. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther 2020;5:113. [PMID: 32616710 DOI: 10.1038/s41392-020-00213-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 29.5] [Reference Citation Analysis]
11 Zhang R, Zhu J, Sun D, Li J, Yao L, Meng S, Li Y, Dang Y, Wang K. The Mechanism of Dynamic Interaction between Doxorubicin and Calf Thymus DNA at the Single-Molecule Level Based on Confocal Raman Spectroscopy. Micromachines (Basel) 2022;13:940. [PMID: 35744554 DOI: 10.3390/mi13060940] [Reference Citation Analysis]
12 Liang P, Ballou B, Lv X, Si W, Bruchez MP, Huang W, Dong X. Monotherapy and Combination Therapy Using Anti-Angiogenic Nanoagents to Fight Cancer. Adv Mater 2021;33:e2005155. [PMID: 33684242 DOI: 10.1002/adma.202005155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
13 Nussinov R, Tsai CJ, Jang H. Anticancer drug resistance: An update and perspective. Drug Resist Updat 2021;:100796. [PMID: 34953682 DOI: 10.1016/j.drup.2021.100796] [Reference Citation Analysis]
14 Lu X, Yan G, Klauck SM, Fleischer E, Klinger A, Sugimoto Y, Shan L, Efferth T. Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK/eIF2α/ATF4 pathway. Biochem Pharmacol 2021;193:114788. [PMID: 34582772 DOI: 10.1016/j.bcp.2021.114788] [Reference Citation Analysis]
15 Dinić J, Efferth T, García-Sosa AT, Grahovac J, Padrón JM, Pajeva I, Rizzolio F, Saponara S, Spengler G, Tsakovska I. Repurposing old drugs to fight multidrug resistant cancers. Drug Resist Updat 2020;52:100713. [PMID: 32615525 DOI: 10.1016/j.drup.2020.100713] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
16 Gonçalves AC, Alves R, Baldeiras I, Marques B, Oliveiros B, Pereira A, Nascimento Costa JM, Cortesão E, Mota Vieira L, Sarmento Ribeiro AB. DNA Methylation Is Correlated with Oxidative Stress in Myelodysplastic Syndrome-Relevance as Complementary Prognostic Biomarkers. Cancers (Basel) 2021;13:3138. [PMID: 34201739 DOI: 10.3390/cancers13133138] [Reference Citation Analysis]
17 Liu J, Yuan Y, Cheng Y, Fu D, Chen Z, Wang Y, Zhang L, Yao C, Shi L, Li M, Zhou C, Zou M, Wang G, Wang L, Wang Z. Copper-Based Metal-Organic Framework Overcomes Cancer Chemoresistance through Systemically Disrupting Dynamically Balanced Cellular Redox Homeostasis. J Am Chem Soc 2022. [PMID: 35192770 DOI: 10.1021/jacs.1c11856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mbaveng AT, Damen F, Guefack MF, Tankeo SB, Abdelfatah S, Bitchagno GT, Çelik İ, Kuete V, Efferth T. 8,8-bis-(Dihydroconiferyl)-diferulate displayed impressive cytotoxicity towards a panel of human and animal cancer cells. Phytomedicine 2020;70:153215. [DOI: 10.1016/j.phymed.2020.153215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
19 Karaosmanoğlu O. P38-β/SAPK-inhibiting and apoptosis-inducing activities of (E)-4-chloro-2-((3-ethoxy-2-hydroxybenzylidene) amino)phenol. Hum Exp Toxicol 2020;39:1374-89. [PMID: 32394730 DOI: 10.1177/0960327120924112] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Rausch M, Rutz A, Allard PM, Delucinge-Vivier C, Docquier M, Dormond O, Wolfender JL, Nowak-Sliwinska P. Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells. Int J Mol Sci 2021;22:6467. [PMID: 34208775 DOI: 10.3390/ijms22126467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang J, Si R, Zhang Q, Pan X, Zhang J. Tumor-microenvironmental-response Bi-functional molecules for efficient imaging and anti-tumor activity therapy. Eur J Med Chem 2022;230:114120. [PMID: 35051748 DOI: 10.1016/j.ejmech.2022.114120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chen J, Gong M, Fan Y, Feng J, Han L, Xin HL, Cao M, Zhang Q, Zhang D, Lei D, Yin Y. Collective Plasmon Coupling in Gold Nanoparticle Clusters for Highly Efficient Photothermal Therapy. ACS Nano 2022. [PMID: 35023718 DOI: 10.1021/acsnano.1c08485] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
23 Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat 2021;:100797. [PMID: 34955385 DOI: 10.1016/j.drup.2021.100797] [Reference Citation Analysis]
24 Yang X, Tian S, Fan L, Niu R, Yan M, Chen S, Zheng M, Zhang S. Integrated regulation of chondrogenic differentiation in mesenchymal stem cells and differentiation of cancer cells. Cancer Cell Int 2022;22:169. [PMID: 35488254 DOI: 10.1186/s12935-022-02598-8] [Reference Citation Analysis]
25 Zhang T, Tai Z, Cui Z, Chai R, Zhu Q, Chen Z. Nano-engineered immune cells as "guided missiles" for cancer therapy. J Control Release 2021;341:60-79. [PMID: 34785315 DOI: 10.1016/j.jconrel.2021.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
26 Su Q, Wang J, Liu F, Zhang Y. Blocking Parkin/PINK1-mediated mitophagy sensitizes hepatocellular carcinoma cells to sanguinarine-induced mitochondrial apoptosis. Toxicology in Vitro 2020;66:104840. [DOI: 10.1016/j.tiv.2020.104840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Heersche N, Veerman GM, de With M, Bins S, Assaraf YG, Dingemans AC, van Schaik RH, Mathijssen RH, Jansman FG. Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Gatenby RA, Brown JS. The Evolution and Ecology of Resistance in Cancer Therapy. Cold Spring Harb Perspect Med 2020;10:a040972. [PMID: 33139405 DOI: 10.1101/cshperspect.a040972] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Chen X, Wang G, Mohammed Alsayed AM, Du Z, Lu Liu, Ma Y, Liu P, Zhang Q, Chen X, Chen W, Ye F, Zheng X, Liu Z. Synthesis and biological evaluation of novel N-substituted benzamides as anti-migration agents for treatment of osteosarcoma. Eur J Med Chem 2021;214:113203. [PMID: 33530028 DOI: 10.1016/j.ejmech.2021.113203] [Reference Citation Analysis]
30 Wang Z, Zhao S, Gu W, Dong Y, Meng F, Yuan J, Zhong Z. α3 integrin-binding peptide-functionalized polymersomes loaded with volasertib for dually-targeted molecular therapy for ovarian cancer. Acta Biomater 2021;124:348-57. [PMID: 33561562 DOI: 10.1016/j.actbio.2021.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Huang WK, Shi H, Akçakaya P, Zeljic K, Gangaev A, Caramuta S, Yeh CN, Bränström R, Larsson C, Lui WO. Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors. Int J Mol Sci 2021;22:10600. [PMID: 34638938 DOI: 10.3390/ijms221910600] [Reference Citation Analysis]
32 Ravindran Menon D, Hammerlindl H, Torrano J, Schaider H, Fujita M. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics 2020;10:6261-77. [PMID: 32483452 DOI: 10.7150/thno.42523] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
33 Kang Z, Wang C, Zhang Z, Liu Q, Zheng Y, Zhao Y, Pan Z, Li Q, Shi L, Liu Y. Spatial Distribution Control of Antimicrobial Peptides through a Novel Polymeric Carrier for Safe and Efficient Cancer Treatment. Adv Mater 2022;34:e2201945. [PMID: 35385590 DOI: 10.1002/adma.202201945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Li J, Sang M, Zheng Y, Meng L, Gu L, Li Z, Liu F, Wu Y, Li W, Shan B. HNRNPUL1 inhibits cisplatin sensitivity of esophageal squamous cell carcinoma through regulating the formation of circMAN1A2. Exp Cell Res 2021;409:112891. [PMID: 34688610 DOI: 10.1016/j.yexcr.2021.112891] [Reference Citation Analysis]
35 Novak Kujundžić R, Prpić M, Đaković N, Dabelić N, Tomljanović M, Mojzeš A, Fröbe A, Trošelj KG. Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer. Int J Mol Sci 2021;22:5681. [PMID: 34073600 DOI: 10.3390/ijms22115681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Jiang W, Xia J, Xie S, Zou R, Pan S, Wang Z, Assaraf YG, Zhu X. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resistance Updates 2020;50:100683. [DOI: 10.1016/j.drup.2020.100683] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
37 Roychoudhury S, Kumar A, Bhatkar D, Sharma NK. Molecular avenues in targeted doxorubicin cancer therapy. Future Oncol. 2020;16:687-700. [PMID: 32253930 DOI: 10.2217/fon-2019-0458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
38 Zhang J, Cunningham J, Brown J, Gatenby R. Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes. Elife 2022;11:e76284. [PMID: 35762577 DOI: 10.7554/eLife.76284] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Cheng JW, Duan LX, Yu Y, Wang P, Feng JL, Feng GZ, Liu Y. Bone marrow mesenchymal stem cells promote prostate cancer cell stemness via cell-cell contact to activate the Jagged1/Notch1 pathway. Cell Biosci 2021;11:87. [PMID: 34001269 DOI: 10.1186/s13578-021-00599-0] [Reference Citation Analysis]
40 Li XY, Pi YN, Chen Y, Zhu Q, Xia BR. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. Front Oncol 2022;12:894744. [PMID: 35756670 DOI: 10.3389/fonc.2022.894744] [Reference Citation Analysis]